
|Articles|November 16, 2022
Trialbee Announces Trialbee Honey™ Omnichannel
Multichannel platform offers tracking for multiple recruitment sources.
Advertisement
Trialbee has announced Trialbee Honey™ Omnichannel, a multichannel approach to global patient recruitment. Honey Omnichannel enables tracking for multiple recruitment sources. The new offering is available in the company’s SaaS-based Trialbee Honey™ platform.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
3
Measuring Whether Site Support Investments Are Actually Working
4
ACT Brief: AI-Enabled Workflow Automation, Subcutaneous Lunsumio VELO Approval, and Pan-KRAS Early-Stage Development
5




